You are here

Trulicity

Diabetes drugs must prove their value to payers, analysts say

Diabetes drugs must prove their value to payers, analysts say

Medical Marketing and Media

Flag link:

Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep

Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep

Fierce Pharma

Flag link:

Eli Lilly wins label expansion for Trulicity injection with basal insulin

Eli Lilly wins label expansion for Trulicity injection with basal insulin

Endpoints

Flag link:

Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth

Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth

Fierce Pharma

Flag link:

One year after FDA nod, Eli Lilly's Trulicity launches first consumer campaign

One year after FDA nod, Eli Lilly's Trulicity launches first consumer campaign

Fierce Pharma Marketing

Flag link:

Once-weekly Lilly diabetes drug wins EU approval

Once-weekly Lilly diabetes drug wins EU approval

Yahoo/Reuters

Flag link:

Infographic – Can Eli Lilly turn up the competitive heat in diabetes?

Infographic – Can Eli Lilly turn up the competitive heat in diabetes?

First Word Pharma

Flag link:

Eli Lilly And The $58 Billion Diabetes Market

Eli Lilly And The $58 Billion Diabetes Market

Bidness Etc.

Flag link:

FDA Approves Lilly's Once-Weekly Shot For Diabetes

FDA Approves Lilly's Once-Weekly Shot For Diabetes

Forbes

Flag link: